PALO ALTO, Calif.--Incyte Pharmaceuticals is about to join the government's human genome sequencing project through a collaboration with the University of Washington in Seattle. The university's sequencing effort, led by Maynard Olson, professor of genetics, molecular biotechnology, and medicine, was recently awarded a three-year, $20 million grant by the US National Human Genome Research Institute, with $7 million of that to be awarded immediately.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.